Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00509717|
Recruitment Status : Completed
First Posted : July 31, 2007
Last Update Posted : July 10, 2008
|Condition or disease||Intervention/treatment|
|Cardiovascular Diseases||Other: intensive implementation programme Other: control|
Cardiovascular disease is the main cause of death in large parts of the world. Next to life style changes, pharmaceutical treatment is a keystone in the treatment of cardiovascular disease. Despite the strong evidence for the effectiveness of lipid-lowering therapy, less than half of the people eligible are treated. With specific medication searches in the community pharmacy database, an easy tool for detecting patients who are undertreated is available. Based on this tool, a pharmaceutical care model for improving underprescription and treatment persistence regarding lipid-lowering medication in patients with cardiovascular disease was constructed.
Moreover, it is not known yet how to implement this pharmaceutical care model in community pharmacies effectively. With multifaceted interventions the behaviour of health professionals can be changed. In this study the effectiveness of a maximal support strategy, including interactive educational meetings, reminders, audit and feedback, is compared to a minimal implementation strategy.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||70 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs. A Randomized Trial.|
|Study Start Date :||October 2006|
|Primary Completion Date :||February 2008|
|Study Completion Date :||March 2008|
Other: intensive implementation programme
educational manual; interactive educational meeting tailored to individual needs; reminders and feedback by 3 newsletters and at least 3 telephone calls.
|Active Comparator: control||
- The percentage of selected (=undertreated) patients receiving at least one prescription for lipid-lowering medication. [ Time Frame: six months after the general practitioner received the list with selected patients ]
- Differences in prescribing for age categories and co-medication. [ Time Frame: six months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00509717
|UMC St Radboud, Scientific Institute for Quality of Healthcare|
|Nijmegen, NL, Netherlands, 6500 HB|
|Principal Investigator:||Peter G. de Smet, PhD||Radboud University|
|Study Director:||Michel Wensing, PhD||Scientific Institute for Quality of Healthcare|